Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Aaron Ahlburn

Managing Director and Senior Director, Research, JLL
Amy Gerber

Executive Managing Director, Business Incentives Practice, Cushman & Wakefield
Bill Luttrell

Senior Locations Strategist, Werner Global Logistics, Werner Enterprises
Bradley Migdal

Senior Managing Director, Business Incentives Practice, Cushman & Wakefield, Inc.
Brian Corde

Managing Partner, Atlas Insight
Dan Levine

Practice Leader, Location Strategies and Economic Development, Oxford Economics, Inc.
Dan White

Senior Economist, Moody's Analytics
Dean J. Uminski, CEcD

Partner, Crowe Horwath
Dennis Cuneo

Partner , Fisher & Phillips
Eric Stavriotis

Senior Vice President, Advisory & Transaction Services, CBRE, Inc.
Gregory Burkart

Managing Director and City Leader, Site Selection & Incentives Advisory , Duff & Phelps, LLC
H. Robert Boehringer, III

Managing Director, Global Location & Expansion Services, KPMG
Josh Bays

Principal, Site Selection Group, LLC
Joshua Wright

VP, Economic and Workforce Development, Emsi
Kate Crowley

Principal & Negotiated incentives Practice Leader, Baker Tilly Virchow Krause, LLP
Les Cranmer

Senior Managing Director, Savills Studley
Marc Beauchamp

President & CEO, The CAI Global Group
Margy Sweeney

Founder and CEO, Akrete, Inc.
Minah Hall

Managing Director, True Partners Consulting LLC
Paul Naumoff

Principal, National Director of Tax Credits & Incentives Advisory Services, EY Global/Americas
Scott Kupperman

Founder, Kupperman Location Solutions
Stephen Gray

CEO, Gray Construction

Pharma Company Plans to Invest $39 Million in NY Facility & Create 350 Jobs

Area Development News Desk

10/20/2011

It's not a "done deal" yet, but InvaGen Pharmaceuticals Inc. may soon be awarded nearly $2 million in New York state tax assistance to build a new factory in Central Islip, NY, which would generate about 350 jobs over five years.

InvaGen President Sudhakar Rao Vidiyala said his company's partnership with state and local governments will allow it to "expand its research and production of pharmaceutical products here."

The project also would double the workforce of the Hauppauge-based firm, which mainly manufactures generic drugs. InvaGen's three existing facilities in Hauppauge employ approximately 330 associates.

The Cuomo Administration has approved the tax credits through the state's jobs program operated via the Empire State Development Corp. The company can use the credits in combination with $4 million local property-tax incentives to offset building expenses. However, it can't obtain the tax credits until certain job requirements are met.

The company also is waiting for FDA approval prior to beginning construction, it has been reported.

"Creating 350 new jobs on Long Island is a real victory for the local economy and a clear sign New York is rapidly becoming a place for businesses growth and success," said Gov. Andrew Cuomo.